Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Lorraine Wean

Pediatrics Greenfield, IN Medical Doctor

NPI 1407858079 CMS profile 18927

300 E Boyd Ave Ste 250, Greenfield, IN 46140

Open in the dashboard

General payments

$4,584

295 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lorraine Wean of Greenfield, IN is reported in the CMS Open Payments database as having received $4,584 across 295 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $650 47
2024 General $1,031 56
2023 General $721 43
2022 General $776 56
2021 General $475 40
2020 General $245 21
2019 General $685 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lorraine Wean
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Lorraine Wean were reported at $650. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Lorraine Wean Pediatrics median Middle half National median
2019 $685 $86 $31–$183 $163
2020 $245 $49 $22–$110 $114
2021 $475 $68 $27–$158 $132
2022 $776 $77 $30–$173 $149
2023 $721 $88 $33–$190 $160
2024 $1,031 $94 $34–$206 $164
2025 $650 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Tris Pharma Inc $1,070 71 payments
  2. Supernus Pharmaceuticals, Inc. $948 54 payments
  3. Corium, Inc. $683 57 payments
  4. Pfizer Inc. $395 29 payments
  5. Ironshore Pharmaceuticals Inc. $291 14 payments
  6. Merck Sharp & Dohme Corporation $269 16 payments
  7. Sanofi Pasteur Inc. $182 9 payments
  8. Cranial Technologies, Inc $142 9 payments
  9. Collegium Pharmaceutical, Inc. $106 5 payments
  10. Adlon Therapeutics L.P. $78 6 payments
  11. Other $422 25 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,577 294 payments
  2. Education $8 1 payment
Products named General payments · program years 2019–2025
  1. Azstarys $683 57 payments
  2. Qelbree Viloxazine Hydrochloride $528 26 payments
  3. Dyanavel XR Adhd $456 26 payments
  4. QELBREE Psychology $412 27 payments
  5. Dyanavel XR Adhd $322 19 payments
  6. GARDASIL 9 $256 15 payments
  7. JORNAY PM $212 9 payments
  8. EUCRISA $204 15 payments
  9. VAXNEUVANCE $176 10 payments
  10. VAXELIS $169 10 payments
  11. Other $2,691 173 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

295 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record